Validation and Comparison between Current Prognostication Systems for Pancreatic Neuroendocrine Neoplasms: Single Institution Experience with 176 Patients
#1800
Introduction: Presently, the optimal prognostication system for pancreatic neuroendocrine neoplasms (PNEN) remains unknown.
Aim(s): To validate and compare the performance of six prognostication systems- the World Health organisation (WHO) 2010 grading criteria, European Neuroendocrine Tumour Society (ENETS) and American Joint Committee for Cancer (AJCC) staging systems, Memorial Sloan-Kettering Cancer Centre (MSKCC) staging and grading systems as well as the Bilimoria criteria in a cohort of patients with PNENs at a single institution.
Materials and methods: A retrospective review of 176 patients with histologically proven PNEN was performed.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Goh B
Authors: Goh B, Teo R, Tai D, Allen J, Lim T,
To read the full abstract, please log into your ENETS Member account.